284 related articles for article (PubMed ID: 1589391)
1. Drug metabolism in the nasal mucosa.
Sarkar MA
Pharm Res; 1992 Jan; 9(1):1-9. PubMed ID: 1589391
[TBL] [Abstract][Full Text] [Related]
2. Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs.
Oliveira P; Fortuna A; Alves G; Falcao A
Curr Drug Metab; 2016; 17(7):628-47. PubMed ID: 27048181
[TBL] [Abstract][Full Text] [Related]
3. Intravail: highly effective intranasal delivery of peptide and protein drugs.
Maggio ET
Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227
[TBL] [Abstract][Full Text] [Related]
4. Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium.
Agu RU; Vu Dang H; Jorissen M; Willems T; Kinget R; Verbeke N
Int J Pharm; 2002 Apr; 237(1-2):179-91. PubMed ID: 11955816
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
[TBL] [Abstract][Full Text] [Related]
7. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
8. Xenobiotic metabolism in the nasal epithelia.
Jenner J; Dodd GH
Drug Metabol Drug Interact; 1988; 6(2):123-48. PubMed ID: 3076530
[TBL] [Abstract][Full Text] [Related]
9. The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption.
Hussain MA; Shenvi AB; Rowe SM; Shefter E
Pharm Res; 1989 Feb; 6(2):186-9. PubMed ID: 2788271
[TBL] [Abstract][Full Text] [Related]
10. Modulating nasal mucosal permeation using metabolic saturation and enzyme inhibition techniques.
Dhamankar V; Donovan MD
J Pharm Pharmacol; 2017 Sep; 69(9):1075-1083. PubMed ID: 28542812
[TBL] [Abstract][Full Text] [Related]
11. Absorption enhancers for nasal drug delivery.
Davis SS; Illum L
Clin Pharmacokinet; 2003; 42(13):1107-28. PubMed ID: 14531723
[TBL] [Abstract][Full Text] [Related]
12. Systemic delivery of peptides and proteins across absorptive mucosae.
Sayani AP; Chien YW
Crit Rev Ther Drug Carrier Syst; 1996; 13(1-2):85-184. PubMed ID: 8853960
[TBL] [Abstract][Full Text] [Related]
13. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
[TBL] [Abstract][Full Text] [Related]
14. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
15. Mucosal drug delivery: membranes, methodologies, and applications.
Song Y; Wang Y; Thakur R; Meidan VM; Michniak B
Crit Rev Ther Drug Carrier Syst; 2004; 21(3):195-256. PubMed ID: 15248809
[TBL] [Abstract][Full Text] [Related]
16. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
Tengamnuay P; Sahamethapat A; Sailasuta A; Mitra AK
Int J Pharm; 2000 Mar; 197(1-2):53-67. PubMed ID: 10704793
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of aflatoxin B1 in the bovine olfactory mucosa.
Larsson P; Pettersson H; Tjälve H
Carcinogenesis; 1989 Jun; 10(6):1113-8. PubMed ID: 2498000
[TBL] [Abstract][Full Text] [Related]
18. Drug development of intranasally delivered peptides.
Campbell C; Morimoto BH; Nenciu D; Fox AW
Ther Deliv; 2012 Apr; 3(4):557-68. PubMed ID: 22834082
[TBL] [Abstract][Full Text] [Related]
19. The nasal delivery of systemic drugs.
Jones NS; Quraishi S; Mason JD
Int J Clin Pract; 1997; 51(5):308-11. PubMed ID: 9489091
[TBL] [Abstract][Full Text] [Related]
20. From nose to brain: understanding transport capacity and transport rate of drugs.
Wu H; Hu K; Jiang X
Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
